The Arab Health 2025 exhibition in Dubai has emerged as a pivotal platform for expanding Russia-India collaboration in pharmaceuticals, biotechnology, and medical research. Key discussions focused on joint R&D initiatives, clinical trials, and the integration of AI in diagnostics and telemedicine.
DRISP led a business delegation of seven Russian industry experts, representing leading medical companies. Their objective was to enhance investment partnerships, establish joint ventures, and expand market presence in India. Arab Health 2025 has reaffirmed its role as a strategic gateway for market expansion and long-term cooperation.
DRISP led a business delegation of seven Russian industry experts, representing leading medical companies. Their objective was to enhance investment partnerships, establish joint ventures, and expand market presence in India. Arab Health 2025 has reaffirmed its role as a strategic gateway for market expansion and long-term cooperation.